432 related articles for article (PubMed ID: 25613725)
1. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
Speck-Planche A; Cordeiro MN
Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
[TBL] [Abstract][Full Text] [Related]
2. New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs.
Speck-Planche A; Kleandrova VV; Cordeiro MN
Eur J Pharm Sci; 2013 Mar; 48(4-5):812-8. PubMed ID: 23376211
[TBL] [Abstract][Full Text] [Related]
3. Chemoinformatics for rational discovery of safe antibacterial drugs: simultaneous predictions of biological activity against streptococci and toxicological profiles in laboratory animals.
Speck-Planche A; Kleandrova VV; Cordeiro MN
Bioorg Med Chem; 2013 May; 21(10):2727-32. PubMed ID: 23582445
[TBL] [Abstract][Full Text] [Related]
4. Optimizing drug discovery using multitasking models for quantitative structure-biological effect relationships: an update of the literature.
Kleandrova VV; Cordeiro MNDS; Speck-Planche A
Expert Opin Drug Discov; 2023; 18(11):1231-1243. PubMed ID: 37639708
[TBL] [Abstract][Full Text] [Related]
5. Advanced In Silico Approaches for Drug Discovery: Mining Information from Multiple Biological and Chemical Data Through mtk- QSBER and pt-QSPR Strategies.
Speck-Planche A; Cordeiro MNDS
Curr Med Chem; 2017; 24(16):1687-1704. PubMed ID: 28120706
[TBL] [Abstract][Full Text] [Related]
6. Speeding up Early Drug Discovery in Antiviral Research: A Fragment-Based in Silico Approach for the Design of Virtual Anti-Hepatitis C Leads.
Speck-Planche A; Dias Soeiro Cordeiro MN
ACS Comb Sci; 2017 Aug; 19(8):501-512. PubMed ID: 28437091
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous virtual prediction of anti-Escherichia coli activities and ADMET profiles: A chemoinformatic complementary approach for high-throughput screening.
Speck-Planche A; Cordeiro MN
ACS Comb Sci; 2014 Feb; 16(2):78-84. PubMed ID: 24383958
[TBL] [Abstract][Full Text] [Related]
8. From Classification to Regression Multitasking QSAR Modeling Using a Novel Modular Neural Network: Simultaneous Prediction of Anticonvulsant Activity and Neurotoxicity of Succinimides.
Antanasijević D; Antanasijević J; Trišović N; Ušćumlić G; Pocajt V
Mol Pharm; 2017 Dec; 14(12):4476-4484. PubMed ID: 29130688
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
10. Multi-Target QSAR Approaches for Modeling Protein Inhibitors. Simultaneous Prediction of Activities Against Biomacromolecules Present in Gram-Negative Bacteria.
Speck-Planche A; Cordeiro MN
Curr Top Med Chem; 2015; 15(18):1801-13. PubMed ID: 25961517
[TBL] [Abstract][Full Text] [Related]
11. In silico assessment of the acute toxicity of chemicals: recent advances and new model for multitasking prediction of toxic effect.
Kleandrova VV; Luan F; Speck-Planche A; Cordeiro MN
Mini Rev Med Chem; 2015; 15(8):677-86. PubMed ID: 25694074
[TBL] [Abstract][Full Text] [Related]
12. Latest advances in molecular topology applications for drug discovery.
Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
[TBL] [Abstract][Full Text] [Related]
13. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
14. Review of current chemoinformatic tools for modeling important aspects of CYPs-mediated drug metabolism. Integrating metabolism data with other biological profiles to enhance drug discovery.
Speck-Planche A; Cordeiro MN
Curr Drug Metab; 2014; 15(4):429-40. PubMed ID: 24909424
[TBL] [Abstract][Full Text] [Related]
15. QSAR studies in the discovery of novel type-II diabetic therapies.
Abuhammad A; Taha MO
Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
[TBL] [Abstract][Full Text] [Related]
16. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
17. A general ANN-based multitasking model for the discovery of potent and safer antibacterial agents.
Speck-Planche A; Cordeiro MN
Methods Mol Biol; 2015; 1260():45-64. PubMed ID: 25502375
[TBL] [Abstract][Full Text] [Related]
18. Enabling virtual screening of potent and safer antimicrobial agents against noma: mtk-QSBER model for simultaneous prediction of antibacterial activities and ADMET properties.
Speck-Planche A; Cordeiro MN
Mini Rev Med Chem; 2015; 15(3):194-202. PubMed ID: 25769968
[TBL] [Abstract][Full Text] [Related]
19. Molecular topology as a novel approach for drug discovery.
Gálvez J; Gálvez-Llompart M; García-Domenech R
Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry.
Speck-Planche A; Cordeiro MN
Curr Top Med Chem; 2013; 13(14):1656-65. PubMed ID: 23889052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
